ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 161

$461K Total Retail Price of All Prescriptions

Rank: 6 out of 161

427 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,382 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 685 588 1 2
FUROSEMIDE 393 372 2 7
OMEPRAZOLE 371 289 3 3
LEVOTHYROXINE SODIUM 343 304 4 1
LISINOPRIL 320 289 5 4
AMLODIPINE BESYLATE 318 304 6 5
POLYETHYLENE GLYCOL 3350 316 241 7 31
METOPROLOL SUCCINATE 313 286 8 13
ALLOPURINOL 275 267 9 28
WARFARIN SODIUM 257 247 10 8
LEVOTHROID 243 217 11 67
POTASSIUM CHLORIDE 239 229 12 11
METFORMIN HCL 213 173 13 9
LOSARTAN POTASSIUM 212 205 14 17
ATORVASTATIN CALCIUM 210 170 15 14
PRAVASTATIN SODIUM 194 161 16 22
METOPROLOL TARTRATE 191 187 17 12
ATENOLOL 165 165 18 19
HYDROCHLOROTHIAZIDE 155 116 19 10
TAMSULOSIN HCL 151 151 20 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 149 21 37
LOSARTAN-HYDROCHLOROTHIAZIDE 148 140 22 30
SPIRONOLACTONE 124 114 23 44
HYDROCODONE-ACETAMINOPHEN 122 82 S3 24 6
GABAPENTIN 111 97 25 15
ENALAPRIL MALEATE 110 110 26 40
SERTRALINE HCL 107 76 27 20
CHLORTHALIDONE 101 86 28 107
PREDNISONE 90 75 29 36
BENAZEPRIL HCL 89 75 30 46
CARVEDILOL 88 85 31 23
FENTANYL 86 83 S2 32 48
CITALOPRAM HBR 83 62 33 21
GLIPIZIDE ER 81 81 34 112
FLUTICASONE PROPIONATE 81 69 34 27
TRIAMTERENE-HCTZ 79 79 36 73
TRAMADOL HCL 74 57 37 16
AZITHROMYCIN 74 60 37 56
PANTOPRAZOLE SODIUM 73 60 39 50
TIZANIDINE HCL 72 57 40 71
LEVETIRACETAM 72 29 40 90
CEFDINIR 72 59 40 124
FLUOXETINE HCL 72 54 40 82
LEVOFLOXACIN 71 67 44 94
RANITIDINE HCL 66 58 45 78
CIPROFLOXACIN HCL 62 50 46 69
GLIMEPIRIDE 62 60 46 32
TERAZOSIN HCL 62 62 46 133
MELOXICAM 60 45 49 18
MIRTAZAPINE 59 46 50 51
ENALAPRIL-HYDROCHLOROTHIAZIDE 58 58 51 140
CRESTOR 57 45 52 39
BISOPROLOL FUMARATE 54 43 53 150
RISPERIDONE 54 25 53 29
ALENDRONATE SODIUM 54 15 53 25
PHENYTOIN SODIUM EXTENDED 53 27 56 153
DOXAZOSIN MESYLATE 53 53 56 153
ISOSORBIDE MONONITRATE ER 53 40 56 63
ZOLPIDEM TARTRATE 53 49 56 26
DONEPEZIL HCL 51 43 60 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.